Cure Alzheimer’s Fund Awards $6.4 Million to Cardinal Family Scholars to Accelerate Alzheimer’s Research

Wellesley Hills, Mass., Sept. 30, 2026 – Cure Alzheimer’s Fund (CureAlz) announced today that it has awarded a total of $6.4 million over the next two years to its second cohort of Cardinal Family Scholars. The funding is aimed at advancing research into Alzheimer’s disease, a progressive neurodegenerative disorder affecting millions worldwide.

The Cardinal Family Scholars program, now in its second cohort, supports promising scientists in their pursuit of innovative Alzheimer’s research. This latest grant brings the total investment in the program to an undisclosed sum, reflecting Cure Alzheimer’s Fund’s continued dedication to funding high-risk, high-reward research. The fund, known for its venture philanthropy model, has been a major supporter of Alzheimer’s research since its founding.

The announcement comes amid growing global concern over Alzheimer’s, which is projected to affect over 150 million people by 2050. The new funding is expected to accelerate research into early detection, prevention, and treatment. While specific research projects were not detailed, the scholars are likely to explore areas such as genetics, biomarkers, and drug development. The next steps will involve the scholars initiating their research projects and reporting findings over the two-year period.